range of biological processes including cell retention for perfusion cultures. In the
TFF system, cell broth is pumped through a dip tube in the lumen of a hollow fiber
module via a peristaltic pump. A simplified overview and description of the setup is
shown in Figure 6.5. This leads to a perpendicular flow of the cell broth to the
permeation direction [19,52]. The hollow fiber module consists of multiple fibers
that are mounted in parallel in the cartridge. Each cartridge has a specific cut-off
(typically 0.1–10 μm) retaining the cells within the hollow fibers, while spent
medium is withdrawn as permeate that is passing through the membrane. Due to the
relatively high shear stress at the filter surface caused by the tangential flow of the
cell broth, filter fouling is reduced, allowing continuous operation and high filtration
flux. Indeed, TFF systems have shown reduced fouling compared to spin filters.
However, shear rates and thus feed flow rates are limited by the shear stress sen-
sitivity of animal cells (Castilho 2002). Although various mammalian and insect
cell lines were shown to survive hydrodynamic stress up to γ = 3,000 s−1 [68] or
γ = 4,000 s−1 [69], values as low as γ = 620 s−1 were shown to be harmful for
suspension HEK293 cells after adenovirus infection [60]. Moreover, since re-
circulation is based on peristaltic pumps, high local shear stress areas are generated
by the pumps further limiting the use for the cultivation of shear stress sensitive cell
lines. This issue can be overcome by implementation of low shear stress centrifugal
Feed pump
HF Membrane
Impeller
pump
Balance
Weight control
Permeate pump
Spent medium
Feed
medium
FIGURE 6.5 Schematic illustration of a setup of a TFF as CRD. Peristaltic pumps or
centrifugal pumps are typically operated in constant or pulsed unidirectional flow. Cell-free
supernatant is constantly removed in a direction orthogonal and radial to the hollow fiber
filters, allowing fresh medium to be added to the bioreactor. Compared to ATF setups (see
Figure 6.6) the working volume in the bioreactor remains constant. Figure adapted from [ 65].
154
Bioprocessing of Viral Vaccines